Table 2.
Variables | PC group (n = 161 patients) | CC group (n = 161 patients) | p value |
---|---|---|---|
Cardiac procedure | |||
Aortic valve surgery | 101 (62.73%) | 61 (37.89%) | <0.0001 |
CABG | 42 (26.09%) | 47 (29.19%) | 0.53 |
Mitral valve surgery | 33 (20.50%) | 65 (40.37%) | 0.0001 |
Aortic valve surgery + CABG | 13 (8.07%) | −17 (10.56%) | 0.4431 |
Tricuspid valve surgery | 1 (0.62%) | 7 (4.35%) | 0.067 |
Aortic valve surgery + ascending aorta surgery and CABG | 0 (0%) | 0 (0%) | 1 |
Aortic valve and ascending aorta surgery | 0 (0%) | 0 (0%) | – |
Ascending aortic surgery alone | 0 | 1 (0.62%) | 1 |
Associated cardiac procedure | |||
LAA closure | 18 (17.1%) | 11 (11%) | 0.2175 |
PFO closure | 4 (3.8%) | 3 (2.8%) | 0.7599 |
PFO closure + LAA | 3 (2.8%) | 1 (1%) | 0.3416 |
Cardiac tumor excision | 1 (0.9%) | 1 (1%) | 0.9667 |
Cardioplegia type | <0.0001 | ||
|
122 (75.78%) | 149 (93.13%) | |
|
39 (24.22%) | 11 (6.88%) | |
CPB and aortic cross clamping data | |||
Minimum haematocrit in CPB | 30 (26; 393) | 27 (23; 30) | 0.078 |
Minimum temperature in CPB | 33.05 (32.7; 33.2) | 33.1 (32.8; 33.2) | 0.73 |
CPB time (min) | 118 (93; 154) | 117 (86; 145) | 0.15 |
Cross‐clamping time (min) | 80.5 (61; 121) | 87 (63; 111) | 0.86 |
Priming volume | 1200 (1000; 1200) | 1200 (1100; 1200) | 0.052 |
Abbreviations: CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass; LAA, left atrial appendage; PFO, patent foramen ovale.